Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 2,740,072 shares of the healthcare conglomerate’s stock after acquiring an additional 156,851 shares during the period. UnitedHealth Group accounts for 1.4% of Mitsubishi UFJ Asset Management Co. Ltd.’s investment portfolio, making the stock its 11th biggest holding. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $1,405,662,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter worth $1,914,740,000. Amundi boosted its stake in shares of UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after buying an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC raised its position in UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its position in UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after purchasing an additional 581,324 shares in the last quarter. Finally, State Street Corp increased its holdings in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of research firms have weighed in on UNH. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $629.32.
UnitedHealth Group Stock Performance
Shares of UnitedHealth Group stock opened at $518.10 on Thursday. The firm has a market cap of $473.92 billion, a PE ratio of 33.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The business’s fifty day simple moving average is $508.60 and its 200-day simple moving average is $545.37. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. The business’s revenue was up 6.8% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.
Insiders Place Their Bets
In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- How to Effectively Use the MarketBeat Ratings Screener
- Energy Transfer: Powering Data With Dividends and Diversification
- 5 Top Rated Dividend Stocks to Consider
- Qualcomm Stock Is Coiling for a Breakout
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.